2.8. Compliance Monitoring and Adverse Events
ADVERSE EVENTS
All participants were asked to return any remaining study products after the intervention. Adherence was measured by calculating all remaining capsules for all patients, including withdrawals. Participants who did not take the supplement for more than two days (either consecutive or non-consecutive) were considered non-compliant (n = 0). All adverse events following administration and intake of the study product were monitored until the end of the study.